An investigation has been undertaken to assess, in vitro, the potentia
l of several pectin formulations as colonic drug delivery systems. Exp
eriments were conducted on the release of model compounds from matrix
tablets under conditions pertaining to those in vivo. The monitoring o
f release gives a sensitive indication of the behaviour of the pectin
under the different conditions. The type of pectin, the presence of ca
lcium and the solubility of the calcium salt all influence release. Ad
ditionally, pectins with a low degree of methoxylation were more susce
ptible to enzymic breakdown. Calcium enhanced the enzymic activity. Rh
eological studies indicated that gel strength was a factor in determin
ing release. These findings suggest that either a high methoxy pectin
formulation or a low methoxy pectin with a carefully controlled amount
of calcium should maximise colonic specificity by providing optimal p
rotection of a drug during its transit to the colon and a high suscept
ibility to enzymic attack.